Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

150 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 37,845,291 shares of 202,731,676 outstanding shares and own 18.7% of the company stock.
Largest 10 shareholders include EVENTIDE ASSET MANAGEMENT, LLC (4,950,000 shares), Deep Track Capital, LP (4,775,000 shares), VANGUARD GROUP INC (3,834,119 shares), BlackRock Inc. (3,325,001 shares), Alpine Global Management, LLC (3,007,000 shares), STATE STREET CORP (2,782,794 shares), EcoR1 Capital, LLC (1,140,819 shares), Point72 Asset Management, L.P. (900,500 shares), TWO SIGMA INVESTMENTS, LP (853,528 shares), and GEODE CAPITAL MANAGEMENT, LLC (820,399 shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.